Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy: PATHOLOGICAL FOUNDATION TO FOCAL THERAPY OF EARLY STAGE OF PROSTATE CANCER